Digital speech markers for monitoring ALS in Spanish speakers
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study uses smartphone or computer recordings to find early changes in speech that may help monitor ALS progression. It focuses on Spanish speakers and may help track how the disease affects speaking over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ALS (often called Lou Gehrig's disease).
- You speak Spanish as your first or only language.
- You can read and write in Spanish.
- Your speech is still relatively clear—for example, you can speak and be understood without much difficulty.
- You do not have other lung conditions like COPD or emphysema, and you do not currently use tobacco.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with ALS and their conversation partners talk with each other. It aims to understand changes in speech and find better ways to support communication.
This study uses smartphone apps and digital tools to track physical changes in people with ALS. It aims to better understand how the disease affects daily function, which could help improve future care.
This study uses a wearable device to track movement patterns in people with ALS. It aims to better understand how the disease affects movement over time, which may help improve care.
This study follows people with ALS and healthy volunteers over time to understand the disease better. You can join from home using a smartphone or computer.
This study continuously measures activity and movement in people with ALS and in control participants. It aims to better understand how muscle disease changes day-to-day function, which may help improve future monitoring or care.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.